ReviewNephrology (Carlton, Vic.)2026
Physiologically-Guided Ultrafiltration: A Proposed Ultrasound Framework for Individualized Volume Removal During Hemodialysis.
Review in Nephrology (Carlton, Vic.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ultrafiltration during hemodialysis is the most hemodynamically stressful intervention dialysis patients endure, yet its prescription relies on interdialytic weight gain and clinical gestalt. Rates exceeding 13 mL/kg/h carry substantially higher cardiovascular mortality, and recurrent intradialytic hypotension drives myocardial stunning, accelerated loss of residual kidney function, and progressive cardiac dysfunction. Existing volume management tools, including bioimpedance spectroscopy, relative blood volume monitoring, and even lung ultrasound, address fragments of this problem but none integrates the two questions that should govern every prescription: how much volume can be removed, and how fast? This review synthesizes principles from critical care hemodynamics and nephrology to propose an integrated ultrasound-guided framework. We apply the Frank-Starling relationship to volume removal, translating the principles of active fluid removal to maintenance hemodialysis. We approach the safety of fluid removal in terms of preload responsiveness: removal is best tolerated when the patient is preload-unresponsive, operating on the flat portion of the cardiac function curve. The framework uses a rapid screen (inferior vena cava diameter and lung ultrasound) to identify patients near dry weight versus those requiring further assessment. When congestion is present, a two-axis decision matrix combines venous congestion quantification (portal vein pulsatility) with preload dependence testing (passive leg raising with a stroke volume surrogate) to guide both volume target and removal rate. Preload responsiveness is defined by a rise of at least 10% to 12% in the left ventricular outflow tract velocity-time integral after passive leg raising, and significant venous congestion by an inferior vena cava diameter of 2 cm or greater with portal vein pulsatility; preload-unresponsive patients without congestion may tolerate rates toward the 13 mL/kg/h safety ceiling, whereas preload-responsive or severely congested patients warrant slower removal over extended or additional sessions. We propose a two-tiered protocol adaptable to diverse practice settings. This integrated framework has not been tested prospectively and should be regarded as hypothesis-generating; that said, the individual components are validated and the physiological rationale is sound, and the potential to reduce ultrafiltration-related morbidity, from intradialytic symptoms to myocardial stunning and residual function loss, is substantial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.